发明名称 REVERSE MICELLE SYSTEM COMPRISING NUCLEIC ACIDS AND USE THEREOF
摘要 The present invention relates to reverse micelle system based on sterols, acylglycerols, phospholipids or sphingolipids and nucleic acids. The reverse micelle system of the invention is able to cross mucosa and cellular membranes. It thus allows vectorization of nucleic acids to target sites. It is advantageously useful in the pharmaceutical and dietetic fields.
申请公布号 US2015050347(A1) 申请公布日期 2015.02.19
申请号 US201414520399 申请日期 2014.10.22
申请人 MEDESIS PHARMA 发明人 MAUREL JEAN-CLAUDE
分类号 A61K9/107;C12N15/113;A61K47/24;A61K31/713;A61K47/28 主分类号 A61K9/107
代理机构 代理人
主权项 1. A method for the delivery of a nucleic acid to a mammal comprising mucosal administration to said mammal of a pharmaceutical composition comprising a pharmaceutically acceptable carrier, excipient or support and a reverse micelle system comprising at least one nucleic acid, a sterol, an acylglycerol, a phospholipid or a sphingolipid, an alcohol and water, wherein the weight ratio of phospholipid or sphingolipid/acylglycerol is from 0.05 to 0.40, said reverse micelle system comprises lecithin as the phospholipid and said reverse micelle system has an aqueous core of between 3 and 5 nm.
地址 Baillargues FR